Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, beta blockers, and aldosterone antagonists have been shown to reduce oxidative stress markers and improve clinical outcomes in HF patients [48]. Here, ACE is linked to hydrops fetalis.